Cargando…
Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
BACKGROUND: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094472/ https://www.ncbi.nlm.nih.gov/pubmed/30111370 http://dx.doi.org/10.1186/s12913-018-3454-6 |
_version_ | 1783347823482241024 |
---|---|
author | Sheu, Shwu-Jiuan Lin, Wen-Liang Kao Yang, Yea-Huei Hwu, Chi-Min Cheng, Ching-Lan |
author_facet | Sheu, Shwu-Jiuan Lin, Wen-Liang Kao Yang, Yea-Huei Hwu, Chi-Min Cheng, Ching-Lan |
author_sort | Sheu, Shwu-Jiuan |
collection | PubMed |
description | BACKGROUND: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. METHODS: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. RESULTS: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64–0.94). CONCLUSIONS: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3454-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6094472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60944722018-08-20 Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan Sheu, Shwu-Jiuan Lin, Wen-Liang Kao Yang, Yea-Huei Hwu, Chi-Min Cheng, Ching-Lan BMC Health Serv Res Research Article BACKGROUND: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. METHODS: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. RESULTS: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64–0.94). CONCLUSIONS: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3454-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-15 /pmc/articles/PMC6094472/ /pubmed/30111370 http://dx.doi.org/10.1186/s12913-018-3454-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Sheu, Shwu-Jiuan Lin, Wen-Liang Kao Yang, Yea-Huei Hwu, Chi-Min Cheng, Ching-Lan Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
title | Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
title_full | Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
title_fullStr | Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
title_full_unstemmed | Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
title_short | Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
title_sort | pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in taiwan |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094472/ https://www.ncbi.nlm.nih.gov/pubmed/30111370 http://dx.doi.org/10.1186/s12913-018-3454-6 |
work_keys_str_mv | AT sheushwujiuan payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan AT linwenliang payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan AT kaoyangyeahuei payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan AT hwuchimin payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan AT chengchinglan payforperformanceprogramreducestreatmentneededdiabeticretinopathyanationwidematchedcohortstudyintaiwan |